University Hospital of South Manchester NHS Foundation Trust (UHSM) selected the Allscripts (Nasdaq:MDRX) SunriseTM platform as its new Electronic Patient Record (EPR) system to enhance care coordination for healthcare providers, patients and families. 
Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it is strengthening its collaboration with Amazon Web Services (AWS) as part of its strategy to enable an ecosystem for new types of connected and personalized digital health solutions. 
When clinicians at Western Sussex Hospitals NHS Foundation Trust sought to become the first in the country to be able to predict when patients were at risk of one of the UK's most deadly conditions, the hospital turned to a small specialist UK company to enter into what would quickly become a strong collaboration. 
Agfa HealthCare will showcase how its Enterprise Imaging for Nuclear Medicine helps nuclear medicine departments excel in efficiency, increase clinical throughput and enhance cross-departmental communication, at the 2015 Congress of the European Association of Nuclear Medicine (EANM), held in Hamburg, Germany, October 10-14. 
IBM (NYSE: IBM) Watson Health and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced that Teva has been selected as its first Foundational Life Sciences Partner for the Watson Health Cloud. As part of this new strategic partnership, Teva becomes the first global pharmaceutical company to tap the power of the Watson Health Cloud to benefit patients and healthcare providers across geographies. 
iMDsoft® announced the release of MetaVision SafeTrack™, its new mobile electronic observation solution. The solution automates Modified Early Warning Scores (MEWS) calculations, nursing assessments and escalations, ensuring timely intervention for patient deterioration. Royal Philips (NYSE: PHG, AEX: PHIA) today announced the appointment of Jan Kimpen as the company’s Chief Medical Officer, effective January 1, 2016. This function will play an increasingly important role in supporting the company's strategic focus on the HealthTech market and Dr. Kimpen will add a wealth of related experience to Philips' senior management team.